BGMS
Cyclacel Pharmaceuticals
BGMS • NASDAQ
Cyclacel Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sing Ee Wong, with a market cap of $4.1M.
CEOSing Ee Wong
Market Cap$4.1M
Biotechnology
Healthcare
Employees12.0
Websitecyclacel.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Cyclacel Pharmaceuticals
Date
Wednesday, April 1, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 1 earnings report for Cyclacel Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$1.31 | — | $81.0K | — | — |